Definition The automotive parking radar market encompasses sensor-based technologies that assist drivers in detecting obstacles during parking or low-speed maneuvers. These systems, commonly referred to as parking sensors or parking assist systems, use ultrasonic, electromagnetic, or radar-based sensing to measure …

Vinca Alkaloid Compounds market was valued at USD 95.9 million in 2024 and is projected to reach USD 160 million by 2031, exhibiting a CAGR of 7.6% during the forecast period.

Drugs for Osteoarthritis Pain Market was valued at USD 9.45 billion in 2024 and is expected to grow to USD 14.44 billion by 2031, registering a compound annual growth rate (CAGR) of 6.4% during the forecast period.

Azelastine market was valued at USD 404 million in 2024 and is projected to reach USD 492 million by 2031, exhibiting a CAGR of 2.9% during the forecast period.

Global vaccine adjuvants market, valued at USD 623 million in 2024, is projected to reach USD 1,152 million by 2031, registering a 9.4% CAGR during 2025–2031.

Medical Radiographic Equipment Market is projected to expand to USD 20.22 billion by 2031, registering a 6.4% CAGR during the forecast period of 2025–2032.

The global reverse transcriptase market, valued at USD 316 million in 2024, is projected to rise to USD 417 million by 2031, advancing at a CAGR of 4.1% over the forecast period

Reverse transcriptase market, is projected to grow steadily and reach USD 417 million by 2031, registering a CAGR of 4.1% during the forecast period.

Chlorhexidine Gluconate API Market is poised for sustained growth, rising from USD 137 million in 2024 to USD 176 million by 2031, registering a 3.8% CAGR during the forecast period.

The global Human Neuregulin Molecule Market, valued at USD 202 million in 2024, is poised for consistent growth, expanding from USD 213 million in 2025 to USD 289 million by 2031, at a CAGR of 5.4%.

Autoimmune disease drugs market is poised for steady expansion, projected to grow from USD 134.92 billion in 2025 to USD 169.34 billion by 2031 at a 3.9% CAGR.

Non-Receptor Tyrosine Kinase Inhibitors (NRTKI) Market is projected to grow from USD 8.45 billion in 2025 to USD 15.02 billion by 2031, registering a strong CAGR of 9.6% during the forecast period.